Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 16699 | 575 | 37.9 | 75% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 232 | 19686 | TAMOXIFEN//AROMATASE INHIBITORS//ANASTROZOLE |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | JIANGDA PATHOL | Address | 3 | 45% | 1% | 5 |
| 2 | APOPTOTIC EFFECTS | Author keyword | 2 | 67% | 0% | 2 |
| 3 | BETA CX | Author keyword | 2 | 67% | 0% | 2 |
| 4 | GEN SURG ONCOL GASTROENTEROL PLAST SURG | Address | 1 | 40% | 0% | 2 |
| 5 | OESTROGEN RECEPTOR BETA | Author keyword | 1 | 13% | 1% | 6 |
| 6 | AFFILIATED RED TEMAT INVEST COOPERAT CANC RTI | Address | 1 | 50% | 0% | 1 |
| 7 | AIB 1 | Author keyword | 1 | 50% | 0% | 1 |
| 8 | CESP EPIDEMIOL POPULAT HLTHUMRS 1018 | Address | 1 | 50% | 0% | 1 |
| 9 | CLIN EPIDEMIOL ENDOCRINOL | Address | 1 | 50% | 0% | 1 |
| 10 | COLONIC CELL LINES | Author keyword | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | APOPTOTIC EFFECTS | 2 | 67% | 0% | 2 | Search APOPTOTIC+EFFECTS | Search APOPTOTIC+EFFECTS |
| 2 | BETA CX | 2 | 67% | 0% | 2 | Search BETA+CX | Search BETA+CX |
| 3 | OESTROGEN RECEPTOR BETA | 1 | 13% | 1% | 6 | Search OESTROGEN+RECEPTOR+BETA | Search OESTROGEN+RECEPTOR+BETA |
| 4 | AIB 1 | 1 | 50% | 0% | 1 | Search AIB+1 | Search AIB+1 |
| 5 | COLONIC CELL LINES | 1 | 50% | 0% | 1 | Search COLONIC+CELL+LINES | Search COLONIC+CELL+LINES |
| 6 | COLORECTAL TISSUES | 1 | 50% | 0% | 1 | Search COLORECTAL+TISSUES | Search COLORECTAL+TISSUES |
| 7 | CYP POLYMORPHISMS | 1 | 50% | 0% | 1 | Search CYP+POLYMORPHISMS | Search CYP+POLYMORPHISMS |
| 8 | DNA MMR | 1 | 50% | 0% | 1 | Search DNA+MMR | Search DNA+MMR |
| 9 | ENDOGENOUS FEMALE HORMONES | 1 | 50% | 0% | 1 | Search ENDOGENOUS+FEMALE+HORMONES | Search ENDOGENOUS+FEMALE+HORMONES |
| 10 | ESTROGEN GROWTH INHIBITION | 1 | 50% | 0% | 1 | Search ESTROGEN+GROWTH+INHIBITION | Search ESTROGEN+GROWTH+INHIBITION |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | EXOGENOUS FEMALE HORMONES | 40 | 76% | 5% | 28 |
| 2 | REPRODUCTIVE HISTORY | 5 | 19% | 4% | 23 |
| 3 | EXOGENOUS HORMONES | 5 | 34% | 2% | 11 |
| 4 | TAMOXIFEN EXPOSURE | 3 | 100% | 1% | 3 |
| 5 | SEX HORMONE RECEPTORS | 2 | 29% | 1% | 7 |
| 6 | 1ST PREGNANCY | 2 | 19% | 2% | 11 |
| 7 | DUODENAL CALCIUM TRANSPORT | 2 | 67% | 0% | 2 |
| 8 | ENDOMETRIAL GLANDULAR CELLS | 2 | 67% | 0% | 2 |
| 9 | INS GAS MICE | 1 | 31% | 1% | 4 |
| 10 | INITIATIVE CLINICAL TRIAL | 1 | 23% | 1% | 5 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Postmenopausal hormone therapy and the risk of colorectal cancer: A review and meta-analysis | 1999 | 318 | 49 | 59% |
| Oral contraceptives and colorectal cancer risk: a systematic review and meta-analysis | 2009 | 26 | 41 | 73% |
| Sex Hormones, Hormonal Interventions, and Gastric Cancer Risk: A Meta-Analysis | 2012 | 28 | 90 | 32% |
| Hormone replacement therapy and the risk of colorectal cancer: A meta-analysis | 1999 | 107 | 31 | 77% |
| Oestrogen and the enigmatic male predominance of gastric cancer | 2008 | 52 | 79 | 51% |
| Oestrogen and colorectal cancer: mechanisms and controversies | 2013 | 5 | 104 | 53% |
| FOREST FIRES IN THE REPUBLIC OF CROATIA (1992-2007) | 2009 | 1 | 1 | 100% |
| Estrogen and gastrointestinal malignancy | 2009 | 21 | 74 | 47% |
| Sex differences in epidemiological, clinical and pathological characteristics of colorectal cancer | 2010 | 36 | 104 | 24% |
| Oestrogen and the colon: potential mechanisms for cancer prevention | 2008 | 59 | 65 | 23% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | JIANGDA PATHOL | 3 | 45% | 0.9% | 5 |
| 2 | GEN SURG ONCOL GASTROENTEROL PLAST SURG | 1 | 40% | 0.3% | 2 |
| 3 | AFFILIATED RED TEMAT INVEST COOPERAT CANC RTI | 1 | 50% | 0.2% | 1 |
| 4 | CESP EPIDEMIOL POPULAT HLTHUMRS 1018 | 1 | 50% | 0.2% | 1 |
| 5 | CLIN EPIDEMIOL ENDOCRINOL | 1 | 50% | 0.2% | 1 |
| 6 | FOOD DIRECTORATEBUR CHEM SAFETYTOXICOL | 1 | 50% | 0.2% | 1 |
| 7 | GE LECHTERFOR MED GIM | 1 | 50% | 0.2% | 1 |
| 8 | KECK MEDSHARON A CARPENTER | 1 | 50% | 0.2% | 1 |
| 9 | MOL GENETHIGASHI KU | 1 | 50% | 0.2% | 1 |
| 10 | SURG TRANSPLANTAT COLON RECTAL SURG | 1 | 50% | 0.2% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000166851 | ESTROGEN RECEPTOR BETA//ER BETA//RECEPTOR BIOL SECT |
| 2 | 0.0000147540 | COLORECTAL ADENOMA//COLORECTAL ADENOMAS//RED MEAT |
| 3 | 0.0000115620 | INTIMA TO MEDIA RATIO//EPIDEMIOL HLTH BEHAV SOC//BIOL DOSE SECT |
| 4 | 0.0000091627 | PROXIMAL SHIFT//SUBSITE//ANATOMIC SUBSITE |
| 5 | 0.0000088625 | FUNCTIONAL BOWEL DISEASE//CA2 ACTIVATED K K CA CHANNEL//ENTERIC DYSMOTILITY |
| 6 | 0.0000066990 | AMPHIREGULIN AREG//IDOXIFENE//DIGEST CARDIOVASC MED |
| 7 | 0.0000065509 | GPR30//GPER//PELP1 |
| 8 | 0.0000063332 | MIN MOUSE//MIN MICE//FAP MODEL |
| 9 | 0.0000062182 | TRANSPLACENTAL METASTASIS//HTB63 HUMAN MELANOMA CELLS//PLACENTAL METASTASIS |
| 10 | 0.0000058543 | DANISH NURSE COHORT//EPES EPIDEMIOL//BENIGN PROLIFERATIVE EPITHELIAL DISORDERS OF THE BREAST |